Research1st

CFIDS Association Welcomes Interim CEO, Maryam Aghamirzadeh

Leigh Reynolds — Wed, 05 Jun 2013 00:47:32 +0000

In anticipation of the April 24, 2013 announcement that longtime CFIDS Association of America president and CEO, K. Kimberly McCleary, would be leaving the Association, the search for an effective interim CEO was already underway. The best interim CEO is one that would be able to effectively lead the team through the transition with a [...]

Survey Highlights Serious Unmet Need for Safe & Effective Treatments

Leigh Reynolds — Wed, 29 May 2013 17:34:12 +0000

On April 25-26, 2013, the U.S. Food and Drug Administration (FDA) held a workshop on drug development related to ME/CFS. This was the first of 20 disease-specific meetings held by the FDA as part of a mandated “Patient-Focused Drug Development Initiative” where the FDA committed to soliciting patient perspectives to inform benefit-risk assessment for drug development. [...]

Putting the Patient at the Center: FDA’s New Series Premiers with ME/CFS

Kim McCleary — Fri, 17 May 2013 22:25:29 +0000

It’s rare that ME/CFS as a disease category experiences a “first” that’s positive. Here’s one worth celebrating: the March 11, 2013 announcement by the Food & Drug Administration (FDA) that ME/CFS would be the first condition explored through the agency’s Patient-Focused Drug Development Initiative. In most of the regulatory framework that guides FDA decisions, information about [...]

CFS Advisory Committee Meets May 22-23

admin — Fri, 10 May 2013 00:48:11 +0000

The federal Chronic Fatigue Syndrome Advisory Committee (CFSAC) meets next on May 22-23, 2013 in Washington, D.C. This chartered advisory committee provides advice and recommendations to the Secretary of Health and Human Services (HHS) through the Assistant Secretary for Health on issues related to ME/CFS. Here is the Federal Register notice announcing the meeting: http://1.usa.gov/15g9vA5 [...]

CFIDS Association Announces Leadership Transition

Board of Directors — Wed, 24 Apr 2013 13:47:35 +0000

The CFIDS Association of America announces that longtime president and CEO, K. Kimberly McCleary, will be leaving her role as the organization’s CEO early this summer. Ms. McCleary joined the CFIDS Association as the organization’s first chief staff executive more than 22 years ago; her family will be relocating in June at which time she will [...]

You’re At the Center: Learn How the CFIDS Association is Fostering Developing of Safe and Effective Treatments for ME/CFS

admin — Mon, 15 Apr 2013 03:46:27 +0000

The fourth webinar in our spring series focuses on how the CFIDS Association is fostering the development of safe and effective therapies for ME/CFS. Please join us!Date/Time (Live Event): Wednesday, April 17, 2013 at 1 p.m. EDT Speakers: Suzanne Vernon, Ph.D. (Scientific Director) and Mark Stone (Director of Development), The CFIDS Association of AmericaRecording: http://bit.ly/apr-17-webinar Dr. [...]

Find Out How FDA Defines “Safe and Effective”: April 11 Webinar

Kim McCleary — Fri, 05 Apr 2013 14:52:23 +0000

View the third webinar in spring series: http://bit.ly/apr-11-webinar, recorded on April 11. In just about two weeks, the U.S. Food and Drug Administration (FDA) will host a two-day workshop on drug development for CFS and ME. The FDA’s review process is designed to test potential treatments for both safety and effectiveness for the condition they aim [...]

Upcoming Webinar: Finding Your Strongest Voice for Public Testimony

admin — Thu, 28 Mar 2013 01:49:46 +0000

The upcoming FDA Workshop on Drug Development is a historic opportunity for the ME/CFS* community to establish ME/CFS as a priority for drug development. Learn more about the FDA workshop here: http://bit.ly/fda-mtg-agenda To inform, educate and engage with the community so that our individual contributions have amplified impact, we are hosting a six-program spring webinar series and [...]

FDA Workshop Agenda & Details Announced

admin — Thu, 21 Mar 2013 19:56:26 +0000

The U.S. Food and Drug Administration (FDA) will host a workshop on drug development and CFS and ME on April 25-26, 2013. This FDA workshop will also serve as the first of 20 disease-specific meetings where the FDA will gather patients’ perspectives as part of a mandated “Patient-Focused Drug Development Initiative.” The CFIDS Association of [...]

Catalyzing Informed Action: Webinar Series & Patient Survey

Leigh Reynolds — Mon, 18 Mar 2013 22:04:36 +0000